| Type | Title | Date Released | |
|---|---|---|---|
8-K | Azora Therapeutics Announces Board Changes, Director Appointments, and Series A Preferred Stock Conversion New | ||
4 | Davidson Matt (Reporting) | ||
4 | Saiki Julie (Reporting) | ||
4 | Coastlands Capital LP (Reporting) | ||
SCHEDULE 13G/A | Coastlands Capital LP (Filed by) | ||
4 | Davidson Matt (Reporting) | ||
3 | Saiki Julie (Reporting) | ||
3 | Economides Vassiliki (Reporting) | ||
8-K | Adial Pharmaceuticals Announces Corporate Name Change to Azora Therapeutics, Leadership Appointments, and Annual Meeting Voting Results | ||
EFFECT | Form EFFECT | ||
10-Q/A | Form 10-Q/A | ||
S-3/A | SHARE RESALE REGISTRATION EFFECTIVE, DATED 2026-10-26 |
